Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Investor Presentation (January 2022)
25 slides from Lifemd's investor presentation, January 2022
Slide 1: Corporate Presentation January 2022
Corporate Presentation January 2022
Slide 2: Important Cautions Regarding Forward-Looking Statements
Important Cautions Regarding Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private
Slide 3: Business Overview
Business Overview 3
Slide 4: A rapidly growing direct-to-patient telehealth company
A rapidly growing direct-to-patient telehealth company leveraging deep expertise in medicine, technology and marketing to make healthcare more accessible, affordable and convenient 50 State Digital Nationwide Pharmacy Provider Network 427K+ Patients 1 Diversified & Growing Brand Portfolio Proprietar
Slide 5: A Differentiated Approach to Telehealth
A Differentiated Approach to Telehealth Diversified Condition-Specific Deep Experience in Direct- Care Strategy Response Marketing Enables smarter acquisition through Relentless focus on optimizing focused treatment offerings and marketing spend, analytics and precision targeting maximizing retentio
Slide 6: LifeMD's Direct-to-Patient Healthcare Experience
LifeMD’s Direct-to-Patient Healthcare Experience Brand Discovery Diagnosis/Screening Virtual Consultation Personalized Treatment Patient views an online or Patient is screened via online An asynchronous or Patient receives personalized offline advertisement and visits intake form and pays for audio/
Slide 7: An End-to-End Telehealth Technology Platform
A platform designed to accommodate a diverse portfolio of DTC telehealth offerings and primary care. Built to handle 50 state daily consult volume at scale without sacrificing quality of care or timely service. A mobile-first primary care platform enhanced by partnerships with Quest Diagnostics, Axl
Slide 8: LifeMD Simplifies Healthcare by Empowering Healthcare Providers & Patients
LifeMD Simplifies Healthcare by Empowering Healthcare Providers & Patients Condition-Specific Care Cost Savings Proprietary Technology Platform Convenience Primary Care Empowers patients with Transparency immediacy, accessibility, and affordability. Single Access Point Empowers doctors with agency,
Slide 9: Our Brands
Our Brands 9
Slide 10: Our Brands Address Large Underserved Markets
>$5.1B Men’s Health Our Brands Address market size Large Underserved Markets ~$2.8B market size Hair Loss Percentage of consumers who would like ~$13.5B market size Allergy & Asthma 75% a wellness visit or physical to be able to happen at home. ~$44B Dermatology market size Percentage of patients wh
Slide 11: RexMD: direct-to-patient telehealth brand for men
RexMDTM is a direct-to-patient telehealth brand that offers virtual healthcare for men nationwide. RexMD offers prescription medications and over-the-counter treatments for Erectile Dysfunction, Premature Ejaculation, Hair Loss, Insomnia, Testosterone Support and more. 4.6 Star Trustpilot Rating 4+
Slide 12: RexMD is the third most popular ePharmacy service, following Amazon
Hims 11% Roman Amazon 11% 29% Capsule 14% RexMD is the third most The Pill Club popular ePharmacy 11% RexMD service, following Amazon 11% & Capsule BlueChew 10% ScriptDrop 8% 12 Source: Yahoo Omnibus, 2021
Slide 13: ShapiroMD hair loss telehealth brand
ShapiroMD® is a direct-to-patient telehealth brand that offers virtual medical treatment for male and female hair loss. ShapiroMD's product portfolio consists of a patented line of OTC products, prescription medications, and an FDA cleared medical device. 4.9 Star Trustpilot Rating Patent Protected
Slide 14: Cleared: allergy, asthma and immunology telehealth
Cleared provides personalized treatments for allergy, asthma, and immunology including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma, and FDA-approved immunotherapies for treating chronic allergies. A first-in-class telehealth destination for bespoke
Slide 15: Two of the most prevalent chronic conditions
Two of the most prevalent chronic conditions 75M 1in 3 The cost to Americans suffer from allergy or asthma U.S. adults suffer society of allergy & asthma now 115 $11B days/ year that the annual U.S. spend exceeds $100 avg allergy sufferer on allergy/ asthma experiences symptoms medications alone bil
Slide 16: NavaMD teledermatology brand
NavaMDTM is a direct-to-patient telehealth brand that combines teledermatology with a patented line of clinically studied OTC skincare products. NavaMD offers virtual treatment and prescription medications for Acne, Anti-Aging, and Rosacea. Powered by LifeMD's 50 State Provider Network Opinion Leadi
Slide 17: LifeMD virtual primary care platform
LifeMD is a personalized, subscription-based virtual primary care platform. The LifeMD primary care clinic provides patients 24/7 access to a high-quality provider for their primary care, urgent care, and chronic care needs. Best-in-class virtual primary care delivered by dedicated providers 24 hour
Slide 18: Financials
Financials 18
Slide 19: Early mover advantage has enabled incredible growth
$142M-$148M Early mover advantage supported by a patient-centric approach has enabled incredible growth $93M $142M-$148M 2022 Revenue Forecast 149% $37M YoY Revenue Growth in ‘21 $13M 427K+ 2019A 2020A 2021P 2022E Patients & Customers To-Date 149% 60% 19 198% 2022 Guidance is as of January 19, 2022
Slide 20: Producing strong results on a sequential basis
Producing strong results on a sequential basis $27.4M $24.9M $22.3M Quarterly Revenue $18.2M $12.9M $11.0M $9.1M $4.3M $3.1M $3.9M Q3 ‘19 Q4 ‘19 Q1 ‘20 Q2 ‘20 Q3 ‘20 Q4 ‘20 Q1 ‘21 Q2 ‘21 Q3 ‘21 Q4 ’21E 20 Q4 2021 revenue represents pre-announced unaudited revenue figures as of January 19, 2022 Press
Slide 21: Driven by Strong KPIs and Compelling Unit Economics
Driven by Strong KPI’s Unaudited, except Revenue and Gross Margin 2019A 2020A 2021E Revenue ($ thousands) Product (Telehealth) $9,929 $30,561 $68,200 Software (WorkSimpli) $2,539 $6,733 $24,700 Total Revenue $12,468 $37,294 $92,900 Subscription Revenue as % of Total 45% 69% 93% Gross Margin % 79% 76
Slide 22: Appendix
Appendix 22
Slide 23: Proven Management Team
Proven Management Team Leadership Team of Industry Experts with a Track Record of Executing Growth Strategies Justin Schreiber Alex Mironov Marc Benathen Stefan Galluppi Brad Roberts Chief Executive Officer President Chief Financial Officer Chief Innovation & Chief Operating Officer Marketing Office
Slide 24: WorkSimpli document services company
WorkSimpli, operating as WorkSimpli Software, LLC, is a rapidly growing Direct-to-Consumer document services company that is expected to provide LifeMD an ample source of liquidity. § LifeMD owns 85.6% of WorkSimpli through a strategic Convert Anywhere, Anytime: Convert PDFs to investment in June 20
Slide 25: Investor Relations and Contacts
Investor Relations Partnership Opportunities Media Relations LifeSci Advisors LifeMD Partnerships Eric Herman [email protected] [email protected] [email protected]